Clin2
NCT04160910Possibly a fitRecruiting

Studying 5HTP to manage asthma symptoms in kids

Mild or Moderate Asthma With Allergic Sensitization

Treatments studied

Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.

This Phase 2 study tests whether 5HTP can help regulate asthma in children and teens who have mild to moderate asthma linked to allergies. It may be an option if your symptoms are allergy-related and you can follow study visits and questionnaires.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
20 people
Ages
8 years to 18 years
Study type
Interventional

Who can take part

  • Be between 8 and 18 years old
  • Have mild to moderate asthma (not severe)
  • Have a positive allergy test (skin test or blood IgE)
  • Weigh at least 70 lbs (32 kg)
  • Not take certain asthma/allergy medicines: no SSRI antidepressants, no montelukast or zileuton, and no biologic asthma shots/infusions (like omalizumab, mepolizumab, benralizumab, or dupilumab)
  • Score high enough on asthma/anxiety symptom questionnaires (CES-DC or SCARED) and be able to attend study visits
  • You (and a parent/guardian, if needed) must be willing to sign consent to join

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07512622Not yet recruiting
Testing a new asthma action plan for teens

This study tests a new way to help teenagers with moderate to severe asthma manage their condition better. Researchers will work with you and your doctor to create a personalized asthma action plan and see if it helps you control your symptoms and reduce flare-ups.

Aurora, Colorado
NCT06023589Recruiting· Phase 3
Testing tezepelumab for kids with severe asthma

This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.

Montgomery, Alabama
NCT07281274Not yet recruiting· Phase 1
Study of ADO-5030 for asthma patients with airway sensitivity

This trial tests a new drug called ADO-5030 in people with mild to moderate asthma to see how it affects their airway sensitivity. Participants will have breathing tests using AMP (a substance that can trigger asthma-like symptoms) to measure the drug's effects.

Charlottesville, Virginia
NCT06679465Not yet recruiting· Phase 4
Study of a single dose of tiotropium for asthma triggered by allergens

This study tests if taking one dose of tiotropium can reduce the breathing trouble caused by allergens (like dust mites or pollen) in people with mild to moderate asthma. It aims to see if this medication can protect your lungs during an allergen challenge.

Saskatoon, Saskatchewan
NCT07643753Not yet recruiting
Exercise program to help young people manage asthma

This study tests whether a structured exercise program helps children and teens with mild, moderate, or severe asthma breathe better and feel more confident. Participants will exercise regularly and share their experiences in group discussions.

Leicester
NCT06837584Not yet recruiting
Managing asthma in children at home

This study tests a way to help control asthma in children aged 2 to 18. It is designed for kids who have had asthma for at least 3 months and had symptoms or treatment in the past year.

Hear when a new Mild or Moderate Asthma With Allergic Sensitization trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.